• What we do

    What we do +

    Bringing cloud based infrastructure, scientific expertise and full service to support the optimal design and efficient management of clinical trials, where imaging provides critical evidence of the novel compound safety and efficacy.

    Imaging Expertise

    Imaging Expertise +

    Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.

    Management

    Management +

    Innovation driven, agile and dedicated team, working in partnership with leading academics and clinical specialists and delivering the best medical imaging solutions and expert advice to ensure success of your clinical study.

    Cloud-Based System

    Cloud-Based System +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Trial Services

    Trial Services +

    We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.

    Therapeutic Areas

    Therapeutic Areas +

    We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.

    Clinical Trial Team

    Clinical Trial Team +

    Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.

    Imaging Expertise

    Imaging Expertise +

    Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.

  • Your Study Initiation

    Your Study Initiation +

    Delivering your study on budget and on time with the cloud based infrastructure, patented scoring methodologies for advanced imaging and a network of therapeutic and imaging experts.

    Case Studies

    Case Studies +

    Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data

    Dynamika for Research

    Dynamika for Research +

    Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment

    Cloud-Based System

    Cloud-Based System +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Connect



    DYNAMIKA USERS:
    E: dynamika @ imageanalysis.org.uk
    T: + 44 20 7630 9926

    PROJECT SUPPORT:
    E: support @ imageanalysis.org.uk
    T: +44 (0) 78 12 001 187



    Discuss your Study (Europe)

    IMAGE ANALYSIS, LTD
    QABC Minster House
    272-274 Vauxhall Bridge Road
    London, SW1V 1BA
    United Kingdom

    T: + 44 (0) 207 630 9926
    E: contact@imageanalysisgroup.com

    Discuss your Study (United States)

    IMAGE ANALYSIS, INC
    10 Trotters Way
    Jackson, New Jersey
    08527
    USA

    T: + 1 215 796-8100
    E: contact@imageanalysisgroup.com

Company News

Towards Enhanced Reproducibility and Understanding of Prostate Cancer through Standardised MRI Acquisition, Analysis and Reporting

By Dr Diana Roettger, Rado Andrian & Dr Olga Kubassova Standardised image acquisition and comprehensive automated analysis of multi-parametric Magnetic Resonance Imaging (mpMRI) are crucial in prostate cancer for optimal diagnosis and therapy and improving patient outcome. There is a clear need for computer-aided analysis and for software which can support clinical workflow to enable faster, more quality-controlled analysis and the extraction of both functional [...]

Comprehensive assessment of the early treatment response in patients with gout – new clinical trial award for Image Analysis Group

England, London, July 18th  2016 -  Image Analysis, announced that it has been awarded a contract for an multi-center gout trial from a leading pharmaceutical company. This project will utilize Image Analysis’ expertise in the collection and manipulation of complex imaging data and includes advanced imaging techniques such as DECT, DCE-MRI in addition to Ultrasound. [...]

Meet Dr Olga Kubassova, CEO at GRAPPA meeting, 14-16 July, Miami, Florida

Dr. Olga Kubassova, CEO and founder of Image Analysis is to attend the Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis to meet clinical and research investigators in the field of psoriasis and psoriatic arthritis. Psoriatic Arthritis (PsA) is a condition which is characterised by inflammation in the synovium [...]

View all news

Blog

Image Analysis collaborates with major German Hospital Charité on the application of MRI in Musculoskeletal Diseases

Image Analysis, Charité – Universitätsmedizin Berlin and Charité Research Organisation to collaborate on furthering Research & Development of contrast enhanced MRI in musculoskeletal conditions. The collaboration will be focusing on projects such as: DCE-MRI analysis in Rheumatoid arthritis DCE-MRI and contrast enhanced Computer tomography (dynCT) comparison DCE-MRI in ankylosing spondylitis The main goals of this [...]

Danger of ‘Gadolinium Phobia’

By Philip Ward, AuntMinnie.com staff writer March 4, 2016 Post European Congress of Radiology (ECR) and publication of several articles in European newspapers, AuntMinnie, the leading radiology news website reports that ‘there’s a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents’. At ECR, Dr. Alexander Radbruch, a radiologist at Heidelberg University [...]

Synovitis in knee osteoarthritis: a precursor of disease?

Synovitis in knee osteoarthritis: a precursor of disease? - another evidence paper confirming the importance of measuring early inflammatory changes occurring prior to degenerative damage in patients with osteoarthritis (OA) is now available on:http://ard.bmj.com/content/early/2014/12/08/annrheumdis-2014-205894.abstract This late 2014 paper has been followed on by a number of research papers confirming the need for earlier biomarkers in OA [...]

View more posts

Latest Tweets

RT @vRad: Report says CAD will dominate #imaging market for next 5 years due to #mammography & #MRI applications http://t.co/Divka2CZWx

RT @BioMedCentral: RT @stefaniealaimo: #MRI detects early effects of #chemotherapy on children’s hearts from @BioMedCentral blog http://t.c…

RT @OlgaKubassova: #Mammography has not reduced deaths from #breast cancer. Real need for effective #imaging for early detection - #MRI htt…

RT @OlgaKubassova: Early Treatment Start Key to RA Remission http://t.co/3AhJWLvqOB

Market growth & overview of #imageanalysis #software market driven by demand for diagnostic procedures & #technology http://t.co/wHoi0He0cL

@sarahhowardview @downingstreet brilliantly :) great event for #smallbusiness and #innovation driven enterprisers http://t.co/wJWvy5bmOe

RT @jemilad: Great talk by @OlgaKubassova on how @ImageAnalysisUK delivers objectivity, efficiency and precision in medical image analysis …